Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

A rare EGFR mutation in newborns leads to severe health issues and early death.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Many patients on new leukemia drugs had mild to moderate skin reactions.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

A blood pressure drug, diltiazem, may also help treat influenza.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Ginsenoside Re from ginseng may help hair grow by blocking a specific growth-inhibiting pathway.

Wnt5a may slow down hair growth in mice.

EGFR deficiency in skin causes hair follicle issues and inflammation.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Removing EGFR in skin causes inflammation and abnormal hair growth.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

EGFR deficiency causes significant changes in skin cells and hair follicles.

Sema3A can both slow and speed up wound healing, depending on its form and combination with EGF.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The enzyme PA-PLA1α is important for proper hair follicle development.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Immune cells affect hair growth and could lead to new hair loss treatments.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.